Purchase Order FA560620P0034
- Not listed
- This firm-fixed-price purchase order contract was awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics GMBH, a for-profit international organization specializing in manufacturing and distributing medical diagnostic systems. The contract, valued at $135,766.54, is for full service analyzer support for ECN 102136. The contract has no set-aside designation and will be performed in Germany, with a period of performance through March 31, 2026. Ortho-Clinical Diagnostics GMBH is...
- The Defense Health Agency awarded a $172,504.53 firm fixed price delivery order to Ortho-Clinical Diagnostics Inc. for the provision of VITROS 5600/XT7600 analyzers, consumables, and cost-per-reportable services for one year. The order is not associated with a set-aside program. Ortho-Clinical Diagnostics is a for-profit medical equipment manufacturer that has provided diagnostic solutions, laboratory equipment, and testing services to various federal healthcare agencies. This delivery order...
- The Defense Health Agency awarded a $212,499.24 firm fixed price delivery order contract to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer, to provide laboratory equipment and services. The contract is under the Critical Analyzers, Laboratory (FSS-66-III) master schedule and has a completion date of June 30, 2026. Ortho-Clinical Diagnostics has previously provided medical equipment, reagents, and testing services to various federal agencies, including the Department...
- This is a $106,717.41 firm-fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer self-certified as a HUBZone joint venture. The contract is for the provision of ORTHO-CLINICAL BLOOD ANALYZER REAGENTS and has an ultimate completion date of November 20, 2028. Ortho-Clinical Diagnostics, Inc. has demonstrated expertise in supplying specialized medical diagnostic equipment and consumables to...
- This is a firm fixed-price federal contract award to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture, by the Defense Health Agency. The $22,000.68 contract is for medical supplies and services, including clinical chemistry analyzers, immunoassay systems, blood typing instruments, and related consumables to support medical testing and diagnostic capabilities across federal healthcare institutions. The award is not associated...
- The Defense Health Agency awarded a firm fixed price delivery order contract to Ortho-Clinical Diagnostics Inc. for cost per test on an immunohematology analyzer. The potential value of the contract is $362,525.23 and the completion date is September 30, 2022. Ortho-Clinical Diagnostics Inc. is a for-profit medical equipment manufacturer that provides a range of diagnostic solutions, including blood bank analyzers, reagents, and test kits, to federal agencies like the Department of Veterans...
- This federal contract award was made by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $636,062.70 firm fixed-price delivery order is for the provision of a chemistry laboratory analyzer, including software, reagents, consumables, accessories, and installation. The contract is not set aside and utilizes the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) schedule. Ortho-Clinical Diagnostics, Inc....
- This is a delivery order contract awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture. The $1,357,664.27 firm fixed-price contract is for the procurement of a chemistry analyzer. The contract has no set-aside designation, indicating open competition. Ortho-Clinical Diagnostics specializes in providing advanced diagnostic solutions, including blood bank analyzers, clinical chemistry...
- This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the provision of chemistry analyzers and reagents. The contract was awarded by the Defense Health Agency, a defense agency, with a ceiling value of $130,080.00 and a period of performance through March 31, 2026. The contract is a delivery order under the Critical Analyzers, Laboratory (FSS-66-III) schedule, and does not have a set-aside designation. Ortho-Clinical Diagnostics,...
- This is a $19,993.16 firm fixed price contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc. for the provision of clinical diagnostic and testing equipment. The award is a blanket purchase agreement (BPA) call and is not set aside. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions to federal agencies, including the Department of Veterans Affairs and Department of Health and Human Services. The company has...
This federal contract award from the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics GMBH, a for-profit international organization, is for the lease of a chemistry analyzer, full service, and delivery of reagents. The firm-fixed-price purchase order has a ceiling value of $395,085.56 and a period of performance through September 29, 2025. The contract is not designated as a set-aside. Ortho-Clinical Diagnostics GMBH is a critical supplier of advanced medical diagnostic technologies, including Ortho Vision Analyzers, Micro Typing System gel cards, and related consumables and maintenance services, to support U.S. government healthcare facilities, particularly military medical centers. The company holds two significant Blanket Purchase Agreements (BPAs) with the Defense Health Agency and the Army Medical Command for the procurement of compatible medical supplies and diagnostic equipment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Exercise an Option | $62.6k | 9/19/24 | |
| P00005 | Exercise an Option | $77.7k | 9/8/23 | |
| P00004 | Vendor Address Change | $0 | 9/5/23 | |
| P00003 | Exercise an Option | $83.8k | 9/20/22 | |
| P00002 | Funding Only Action | ($14k) | 7/20/22 |